The emerging treatment of the medication represents a major advance in the management of type 2 diabetes. Different to existing therapies, tirzepatide impacts dual pathways – the GLP-1 hormone and GIP – resulting https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment